Revive Therapeutics Ltd.
CNQ: RVV.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Michael Frank
- Employees
- 2
- Headquarters
- Toronto, Canada
- IPO year
- 2013
- Market cap
- CA$13.1M
- Website
- https://www.revivethera.com
Loading RVV…
Loading profile data…Frequently asked questions about RVV
What does Revive Therapeutics Ltd. (RVV.CN) do?
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious...
Where does RVV.CN trade?
Revive Therapeutics Ltd. (RVV.CN) trades on the Canadian Securities Exchange.
What sector is RVV.CN in?
Revive Therapeutics Ltd. (RVV.CN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Revive Therapeutics Ltd.?
Michael Frank is the chief executive officer of Revive Therapeutics Ltd. (RVV.CN).
Where is Revive Therapeutics Ltd. headquartered?
Revive Therapeutics Ltd. is headquartered in Canada.
Does RVV.CN pay a dividend?
Revive Therapeutics Ltd. (RVV.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RVV.CN go public?
Revive Therapeutics Ltd. (RVV.CN) completed its initial public offering in 2013.